ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Therapy: Adhering to Treatment/Modes of Treatment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 86215" data-attributes="member: 2624"><p>An older study, but one worth considering.</p><p></p><p>To determine which modes of treatment resulted in the highest rates of adherence, a retrospective claims database study from January 2005 through December 2011 was undertaken. The study included 106,039 men, 18-65 years of age who had initiated TRT and were diagnosed with hypogonadism or hypogonadotropic hypogonadism. A minimum of 6 months continuous enrollment before and 12 months after the TRT index date was required. Adherence was measured by the Mediation Possession Ratio (MPR) and the Proportion of Days Covered (PDC), with the adherence rate defined as MPR&#8805;0.8. The rate of the first switching was summarized by TRT formulation.</p><p></p><ul> <li data-xf-list-type="ul">The overall adherence rate over 12 months was 21.4% ranging from 28% (pellets), 19.9% (SAIs), 17.7% (gels), 7.8% (buccal), and 6.6% (patch), respectively. Similarly, the average PDCs were significantly higher for pellets (0.59) compared to gels (0.43), SAIs (0.39), buccal (0.28), and patch (0.27) (P<0.001). About 13% (n = 13,577) of patients switched from their initial therapy to a different TRT formulation. Patients starting with patch were most likely to switch to a different formulation (39.3%), followed by patients with SAIs (12.1%), pellets/buccal (12.0%), and gels (10.3%).</li> </ul><p></p><p>"Medication adherence and switching rates of patients with testosterone replacement therapy (TRT) in the United States," <em>Value in Health Journal, </em>May 2014, <a href="http://www.valueinhealthjournal.com/article/S1098-3015(14)01586-1/fulltext" target="_blank">http://www.valueinhealthjournal.com/article/S1098-3015(14)01586-1/fulltext</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 86215, member: 2624"] An older study, but one worth considering. To determine which modes of treatment resulted in the highest rates of adherence, a retrospective claims database study from January 2005 through December 2011 was undertaken. The study included 106,039 men, 18-65 years of age who had initiated TRT and were diagnosed with hypogonadism or hypogonadotropic hypogonadism. A minimum of 6 months continuous enrollment before and 12 months after the TRT index date was required. Adherence was measured by the Mediation Possession Ratio (MPR) and the Proportion of Days Covered (PDC), with the adherence rate defined as MPR≥0.8. The rate of the first switching was summarized by TRT formulation. [LIST] [*]The overall adherence rate over 12 months was 21.4% ranging from 28% (pellets), 19.9% (SAIs), 17.7% (gels), 7.8% (buccal), and 6.6% (patch), respectively. Similarly, the average PDCs were significantly higher for pellets (0.59) compared to gels (0.43), SAIs (0.39), buccal (0.28), and patch (0.27) (P<0.001). About 13% (n = 13,577) of patients switched from their initial therapy to a different TRT formulation. Patients starting with patch were most likely to switch to a different formulation (39.3%), followed by patients with SAIs (12.1%), pellets/buccal (12.0%), and gels (10.3%). [/LIST] "Medication adherence and switching rates of patients with testosterone replacement therapy (TRT) in the United States," [I]Value in Health Journal, [/I]May 2014, [URL]http://www.valueinhealthjournal.com/article/S1098-3015(14)01586-1/fulltext[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Therapy: Adhering to Treatment/Modes of Treatment
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top